Introduction
Retinoic acid (RA) is an important morphogen in the development of many organ systems includ ing heart, eyes, hindbrain, spinal cord and urogeni tal system. All retinoids derive from carotenoids, accessory pigments for photosynthesis in plants. In vertebrates they are oxidized to RA, which acts as the biologically active transcriptional activator (for review see Dräger and McCaffery, 1997; Kochhar, 1997; Durston et al., 1999) . In this review I suggest that RA is a regulator of gene transcrip tion not only in embryonic development but also in physiological responses to injuries of the adult nervous system. Especially in the central nervous system (CNS) nerve injuries constitute a problem of clinical relevance: Whereas the transection of a peripheral nerve can be followed by successful restoration of function, lesions in the CNS cause permanent damage. Here, injured nerve cells not only fail to regenerate their axons but suffer de generative changes and eventually die. Among other causes this difference is due to the fact that the non-neuronal constituents of CNS (astrocytes, oligodendrocytes, microglia) and peripheral ner vous system (PNS; Schwann cells, fibroblasts, ma crophages) activate different pathways of intercel lular signal transduction. In order to understand success or failure of axonal regeneration, it is therefore promising to investigate the cellular in teractions that take place in the different environ ments of CNS and PNS.
An acute injury to the mammalian CNS triggers a complex set of physiological reactions, largely determined by the activation of microglia cells and (1) Mesodermal microglia cells infiltrate the CNS during early development and remain there in a resting state (Raivich et a l, 1999) . Activated by a lesion, the microglia approach injured nerve cell bodies, displace synaptic connections and prolifer ate. The cells then become phagocytotic, attack in jured nerve cells and remove cellular debris from degenerating neurons and myelin (Blinzinger and Kreutzberg, 1968; Thanos et a l, 1993) . (2) Astrocytes, the predominant neuroglial cells of the CNS, also respond to an injury with morphological changes, accompanied by the upregulation of glial fibrillary acidic protein (Graeber and Kreutzberg, 1986) . Later, astrocytes form a physical barrier be tween damaged and intact tissue, the glial scar. To gether with inhibitory molecules in the CNS-myelin (Caroni and Schwab, 1988; 2000) , the glial scar inhibits axonal regeneration (Liuzzi and Lasek, 1987; Puckett et al., 1997) . (3) Axotomized nerve cells in the brain react with chromatolytic swelling of the perikarya and neurite sprout ing at the site of injury. In the inhibitory environment of the CNS, however, this remains ineffective and is generally followed by cell death. In addition to the glial reaction, the posttraumatic cell death causes infiltration of lymphocytes from the blood vessels (Raivich et a l, 1998) .
In contrast to the CNS, peripheral nerve fibers are able to regenerate well after a traumatic injury. The physiological responses to the transection of a peripheral nerve consist of two phases: Wallerian degeneration and regenerative growth processes (Mey and Thanos, 1996; Gillen et a l, 1997) . (1) The term Wallerian degeneration refers to the breakdown and phagocytosis of the nerve segment that is distal to a lesion. Degeneration includes also neuronal cell body reaction, myelin break down, cellular infiltration of macrophages from the blood, de-differentiation and proliferation of Schwann cells. (2) The phase of regeneration be gins with metabolic changes by the affected nerve cells. Axons then extend from the lesion site, Schwann cells differentiate again and ensheathe the new fibers with myelin. Finally target organs can be re-innervated.
On the molecular level these cellular responses are accomplished by the differential transcription of a large number of structural and regulatory genes. For instance, mRNAs of transmitters and myelin specific genes decline in the degeneration phase, and those of lipid carrier proteins like apolipoproteins D and E increase in the regeneration phase of peripheral nerves (Gillen et al, 1997; Rai vich et al, 1999) . How are these cellular interac tions regulated? To a large extent this is a function of cytokine signaling. Although the differential ex pression of a large number of cytokine and cytok ine receptor genes has been described, much less is known about their transcriptional control. I sug gest that RA plays an important role in the regula tion of cytokine signaling after nerve injury. To support this hypothesis I will review some facts about differential cytokine expression after nerve lesions, present data on cytokine regulation by RA, and discuss evidence for the relevance of RA in axonal regeneration.
Differential cytokine expression after nerve injury
Cytokines have been described as intercellular mediators that regulate the immune response dur ing infections, inflammatory reactions, and neuro logical and endocrinological autoimmune diseases. Unlike hormones, cytokines are not stored in glands, then released into the bloodstream, but are synthesized and secreted locally and in relatively small amounts (Heinrich et al., 1998 ). On the mo lecular level of description, cytokines are a diverse group of secreted proteins with small molecular weight (6-26 kDa). They are produced by all cell types that participate in the traumatic interactions after a nerve injury. Cytokines initiate their actions by high affinity binding (dissociation constants < 10" 1 0 M) to specific cell-surface receptors, which in turn activate intracellular messenger systems, involving protein kinase or phosphatase pathways (Zhao and Schwartz, 1998) . After nerve injuries in the PNS (sciatic nerve, facial nerve) or CNS (optic nerve, cerebral cortex) the following cytokines have been discovered to be differentially ex pressed.
Interleukin-1 (IL-1) family
Most biological functions of these pro-inflam matory cytokines are transmitted by IL-lß. This, but not IL-la, requires an IL-l-converting enzyme for its activation. In addition to IL -la and IL-lß a third member of this family is the IL-1 receptor antagonist (IL-lra), which blocks transmission by competitive inhibition of their receptor (Gutierrez et al., 1994) . Within 1 -3 hours after a peripheral nerve lesion IL-lß bioactivity as well as its mRNA levels increase dramatically. In the rat sciatic nerve infiltrating macrophages secrete IL-lß. This binds to Schwann cells and induces the synthesis of nerve growth factor (NGF), granulocyte macro phage colony stimulating factor (GM-CSF) and in creases the stability of NGF mRNA (Lindholm et al., 1987; Lindholm et al., 1988) . A positive influ ence on wound repair is also suggested (Streit et al., 1998) . In combination with fibroblast growth factor-2 (FGF-2) IL -la supports neurite out growth from dorsal root ganglion explants in three-dimensional astrocyte cultures (Fok-Seang et al., 1998). In contrast to these bona fide beneficial effects, the upregulation of IL-lß in the CNS has been implicated in ischemic, traumatic or excitotoxic damage. Inhibition of IL-1 synthesis or ad ministration of IL -lra reduced neurodegeneration in these cases (Rothwell, 1998) .
Interleukin-6 (IL-6) type cytokines
Leukemia inhibitory factor (LIF), IL-6 , ciliary neurotrophic factor (CNTF) and other related molecules are referred to as neuropoietic cytok ines and share a common signaling pathway, in volving the gpl30 cell membrane receptor plus one or two more specific receptors. Ligand binding leads to the activation of gpl30-associated kinases (Jakl, Jak2, Tyk2). They phosphorylate gpl30 and factors of the STAT family (signal transducer and activator of transcription), which dimerize, trans locate to the nucleus, and bind to enhancer ele ments of respective target genes (Heinrich et al., 1998) . Within 24 hours after rat sciatic nerve in jury, LIF protein increases in Schwann cells close to the lesion site. In addition to the signaling path way described above, LIF is retrogradely trans ported in the axons and then functions as a neurot rophic factor for sensory and motoneurons. In cultured Schwann cells LIF is induced by TGF-ßl (Matsuoka et al., 1997) . Neurotrophic properties are also reported for CNTF (Sendtner et al., 1990; Mey and Thanos, 1993) . This cytokine is present in large amounts in the cytoplasm of Schwann cells of non-injured nerves. Although expression of the CNTF gene is downregulated due to the injury, cell damage causes release of CNTF from those cells (Sendtner et al., 1992) . CNTF, which is also taken up and retrogradely transported, prevents the degeneration of motoneurons (Sendtner et al., 1990) . They subsequently become sensitive to LIF (Haas et al., 1999) . IL-6 is not detected in the adult PNS but is induced by nerve injury in many largeand medium sized neurons (Murphy et al., 1995). Its expression (as well as that of GM-CSF mRNA) rises dramatically in sheath cells of the injured PNS and CNS. IL-6 has a minor effect on neuronal survival (Murphy et al., 2000) , yet supports macro phage activity like myelin breakdown, which in turn stimulates Schwann cell proliferation and ax onal regeneration (Gillen et al., 1997) . After facial nerve transection, IL-6 participates in the activa tion of astrocytes and, indirectly, microglia cells (Klein et al., 1997; Raivich et al., 1999). In acti vated astrocytes, the primary targets of IL-6 , this cytokine induces the production of NGF (Kossmann et al., 1996) . Recently a new ligand for the CNTF-R has been characterized, a complex con sisting of the soluble receptor cytokine-like factor-1 and cardiotrophin-like cytokine (CLF/CLC). This secreted heterodimer supports motor neuron survival and may be responsible for many biologi cal functions of the CNTF-signaling pathway that could not be accounted for in development, be cause CNTF lacks a signal sequence and is barely detectable in the embryonic CNS (Elson et al., 2000) . A possible involvement for CLF/CLC in nerve injury will certainly be investigated. Recep tor genes for neuropoietic cytokines in peripheral nerves likewise responds to nerve injury with dis tinctive expression patterns Haas et al., 1999) . CNTF-Ra mRNA levels, which are low in the intact nerve, increase gradually during three weeks after nerve crush or transection, then return to normal. LIF-Rß mRNA concentration is fairly high but shows a transient decrease after the lesions. IL-6 -R a expression increases rapidly within 2 days, then declines steadily. Finally, the gpl30 mRNA concentration follows a similar pattern but expression remains high for a longer period, in the regeneration paradigm (crush) for at least 4 weeks and for 2 weeks in the distal part of transected nerves . The situation appears different for the neuronal component (ax ons, somata) where receptors for neuropoietic cy tokines are expressed constitutively. After transec tion of the facial nerve CNTF-Ra mRNA and protein were found to be downregulated, LIF-Rß upregulated, and gpl30 unchanged in the brains tem nucleus of the facial nerve. Intracellular signal transduction (STAT-3 phosphorylation) was acti vated in the brain (Haas et al, 1999) . The neuropoietic cytokines are key players in the mediation of inflammatory reactions. At least three of them, CNTF, CLF/CLC and LIF, exert a positive influ ence on the homeostasis of injured neurons.
Transforming growth factor-ß (TGF-ß) family
Different members of the TGF-ß family appa rently fulfill very different functions. TGF-ßl is an anti-inflammatory cytokine with neurotrophic and immunosuppressive properties. From a low level of expression in the normal sciatic nerve, TGF-ßl is upregulated to reach a maximum concentration within 4 days after injury. TGF-ßl stimulates Schwann cell proliferation and regulates the ex pression of other downstream genes like neural cell adhesion molecule (N-CAM). On the other hand, TGF-ß3 is downregulated immediately after nerve transection, although its mRNA level rises with subsequent axonal regeneration (Rufer et a l, 1994; Gillen et a l, 1997). Levels of TGF-ß2 protein in the lesioned peripheral nerve are low and may derive from the blood (Rufer et al, 1994; Mey and Thanos, 1996) . TGF-ßl and TGF-receptor expres sion also increase after CNS-lesions and in most forms of brain pathology (Raivich et al, 1999) . While TGF-ßl deficient mice show a reduction of microglia and an increase in astrocyte activation, exogenous application of TGF-ßl or transgenic overexpression enhanced glial scarring and extra cellular matrix deposition (Logan et a l, 1994; Hamada et a l, 1996; Jones et a l, 1998). Thus, TGF-ß cytokines exert both beneficial and inhibitory ef fects on nerve regeneration.
Neurotrophins (NT)
The four neurotrophins, nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), neurotrophin-3 (NT-3) and NT-4/5, are probably the best known regulators of neuronal survival and connectivity (Bregman et a l, 1997; Bartheld, 1998; Kaplan and Miller, 2000) . All are differentially regulated after injury (Hefti, 1994; Gillen et al, 1997) . Neurotrophin receptors belong to one family of receptor tyrosine kinases (Trk) with specificity for NGF (TrkA), BDNF and NT-4/5 (TrkB), and NT-3 (TrkC), although NT-3 is somewhat promiscuous (Barbacid, 1994) . The re cently discovered NT-6 and NT-7 also bind to TrkA . In addition, there exists an unspecific low affinity neurotrophin re ceptor p75, which has been implicated in NGFinduced cell death (Frade et a l, 1996; Frade and Barde, 1998; Kaplan and Miller, 2000) . Triggered by a peripheral nerve injury NGF expression goes up in a biphasic response in Schwann cells. Its mRNA level rises transiently after a few hours, drops and increases again after 3 days, remaining high during the phase of regeneration (Heumann et a l, 1987; Hengerer et a l, 1990). In the sciatic nerve NGF appears to be regulated by IL-lß, though this may be an indirect effect, since IL-1 and tumor necrosis factor-a (TNF-a) can induce IL-6 synthesis, which in the CNS enhances the re lease of NGF by astrocytes (Zhao and Schwartz, 1998) . BDNF shows a similar response as NGF, although in neurons, while it is upregulated in Schwann cells during remyelination several weeks later. In the motoneurons, BDNF expression then decreases concomitant with axonal regeneration (Meyer et a l, 1992 ). NT-3 and NT-4, in contrast, decline in response to the injury. Paradoxically, neurotrophin production also increases in the in jured CNS where no regeneration is possible (McKeon et a l, 1997) . The transcription of neurot rophin receptor genes changes also after nerve transection, which prevents axonal regeneration in the periphery: An increase is observed with TrkB and TrkC in Schwann cells proximal to the lesion, p75 proximal and distal to the lesion. TrkB and TrkC are downregulated in Schwann cells distal to the lesion, p75 in sensory and motoneurons (Gil len et al, 1997). In response to a CNS lesion, astrocytes express the full-length TrkB receptor (McKeon et al, 1997) . Of all the intercellular sig nals, discussed here, the neurotrophins appear to be the most important ones to produce direct ef fects on neurons.
Other cytokines and synergistic effects
The production of insulin like growth factor (IGF)-I and its receptor increase in parallel with the proliferation of non-neuronal cells. Since IGF-II expression rises later it has been implicated in axonal regeneration and neuromuscular synaptogenesis. IGF-I has beneficial effects in several neurodegenerative diseases like amyotrophic lateral sclerosis, experimental allergic encephalomyelitis and neuromuscular atrophies (Dore et al., 1997) . Treatment of CNS disorders is difficult with IGF, because it cannot pass the blood-brain-barrier. Many other cytokines including interferon-y (IFNy), tum or necrosis factor-a (TN F-a) and IL-10 also participate in degenerative and regenerative pro cesses (Gillen et al., 1998; Spera et al., 1998) . TNFa induces macrophage recruitm ent from the pe riphery, though it has no direct effect on phagocy tosis (Liefner et al., 2000) . The discussion above made it clear that a number of synergistic effects exist between various classes of cytokines. A n other example, recently discovered, is the recipro cal action between IL-6 and BDNF in adult dorsal root ganglion neurons. Treatment with functional antibodies in vivo and results from mice with null m utation of the IL-6 gene suggest that the increase of BDNF after nerve injury in normal mice and rats is caused by this neuropoietic cytokine (M ur phy et al., 2000) . With cultures of PC12 cells a re verse interaction between neurotrophin and IL-6 is observed: N G F exerts a negative effect on STAT3, whose activation is inhibitory to neurite growth in this cell line (Ihara et al., 1997) .
Regulation of cytokine expression by retinoic acid
In embryonic development retinoic acid (R A ) regulates glial and neuronal cell differentiation by activating a family of DNA-binding nuclear tran scription factors, the retinoic acid receptors (R A R ) and retinoid x receptors (RxR) . Among the targets of this transcriptional control are a multitude of structural genes, transcription factors, cell surface molecules and also many cytokines (Gudas et al., 1994) . Our knowledge about the in fluence of R A on cytokine expression derives al most entirely from cell culture experiments, often with immortalized cell lines not related to the ner vous system.
The pro-inflammatory cytokines IL -la and ILlß are induced by R A in most experiments, whereas the expression of IL-6 is suppressed or enhanced depending on the cell culture system Abbreviations: IL, interleukin; GM-CSF, granulocyte monocyte colony stimulating factor; CNTF, ciliary neurotrophic factor; M-CSF, macrophage colony stimulating factor; -R, -receptor; LIF, leukemia inhibitory factor.
( Table I ). While the production of IL-1 itself may be supported by retinoids, RA sometimes counteracts downstream effects, for instance the IL-l-induced synthesis of other cytokines (Gross et al., 1993) . RA induces the synthesis of CNTFreceptor-a m RNA in embryonic chick ciliary gan glion neurons, and this correlates with an increase in activation of CNTF-dependent intracellular sig nal transduction, in this case phosphorylation of STAT-3 (Wang and Halvorsen, 1998) . Regulation of the various receptors for neuropoietic cytokines depends strongly on the cell culture system with contradicting results even for closely related cell types (Chen et al., 1999) . The expression of TGF-ß cytokines, which often have a beneficial influ ence on neuronal survival and regeneration, is generally increased with RA treatm ent (Table II) .
Since the primary function of neurotrophins is seen in the regulation of nerve cell survival and neuronal connectivity, their regulation by R A im plies the closest connection between retinoids and nerve regeneration (Table III) . Most investigators who dem onstrate a supportive effect by R A on axon growth or neuronal survival suggest the tran scriptional activation of the neurotrophin receptor genes as the functional mechanism (Kaplan et al., 1993; Holst et al., 1995; Plum and Clagett-Dame, 1996; Ahlem eyer et al., 2000) . The importance of RA for neurotrophin receptor expression has been studied most thoroughly in developing sympa thetic ganglia of chicken, rat and mouse (Rodrfguez-Tebar and Rohrer, 1991; Holst et al., 1995; Holst et al., 1997; Kobayashi et al., 1998; Wy att et al., 1999) . Although there seem to be major differences in the effect of retinoids on expression of receptor tyrosin kinases in sympathetic neuro blasts of birds and mammals, experiments with specific agonists and antagonists suggest that en dogenous R A acts on Trk genes via activation of R A R a in both classes of vertebrates (Holst et al., 1995; Wyatt et al., 1999) .
Glial cell line-derived neurotrophic factor (GD NF) is another type of cytokine involved in neuronal development. Its specific receptor, GF-R a l, is upregulated by RA also by way of the nuclear receptor R A R a (Thang et al., 2000) . In addition to these cytokines, R A affects many dif ferent signal transducers with a function in trau matic reactions of the nervous system (Table IV) .
A nother im portant pathway of intercellular in teraction requires direct cell-cell contact, mediated via cell adhesion molecules of the immunoglobulin superfamily, Ca2+-dependent cadherins, and integrins, the receptors for extracellular matrix mole cules (DiProspero et al., 1997; Werner et al., 1998) . These are other candidates for targets of transcrip tional regulation by retinoids. In F9 teratocarcinom a cells and smooth muscle cells, RA increased the amount of ß l integrin, a laminin/fibronectin receptor subunit. This led to increased adhesion Abbreviations: TGF, transforming growth factor; TGF-R. transforming growth factor receptor. Thang et al., 2000 Abbreviations: IL, interleukin; IGFBP, insulin-like growth factor binding protein; E A E, experimental allergic en cephalomyelitis; TNF, tum or necrosis factor; IFN, interferon;, GF-R, glial cell line-derived neurotrophic factor recep tor.
on laminin (Ross et al., 1994) and fibronectin (M edhora, 2000) . A substrate-specific effect of RA on the length of neurites has also been re ported for developing olfactory neurons grown on laminin (Whitesides et al., 1998) . A fter facial nerve transection a biphasic upregulation of intercellular adhesion molecule-1 (ICAM-1 or CD54) was ob served. The response, which is attributed to acti vated microglia and in a second phase also to infiltrating lymphocytes, correlates with phagocytotic activity and microglia-lymphocyte interac tions (W erner et al., 1998) . Again, in an unrelated line of research, R A was found to be involved in the regulation of ICAM-1. When induced by TNFa the ICAM-1 expression in epidermal keratinocytes was enhanced by R A (Janssens et al., 1999) .
Retinoic acid and axonal regeneration
Since RA inhibits proliferation of several im mortalized cell lines, many cell culture experi ments with retinoids are connected to cancer-research. In these a num ber of neuroepithelial cell lines can be driven to develop neuronal (JonesVillenueve et al., 1983; Kaplan et al., 1993; or glial (Staines et al., 1996; Tokumoto et al., 1999) characteristics.
R A induces differentiation o f neurons and glial cells
During embryonic development of the nervous system R A is an im portant regulator of cell differ entiation, affecting oligodendrocytes (Noll and Miller, 1994; Staines et al., 1996) , astrocytes (Wuarin et al., 1990) and nerve cells (Henion and Wes ton, 1994; Thang et al., 2000) . The effect of RA on neuronal differentiation has been studied exten sively with embryonal carcinoma cells, where a large num ber of RA-induced and repressed genes were identified (Bouillet et al., 1995; Oulad-Abdelghani et al., 1998; . Neuronal development requires the outgrowth of axons. In cell culture experiments with embryonic tissue RA increased axonal out growth from spinal cord (Wuarin et al., 1990; H unter et al., 1991; Wuarin and Sidell, 1991; M a den et al., 1998), dorsal root ganglia (DRG; H as kell et al., 1987) , cerebellum (Yamamoto et al., 1996) and sympathetic ganglia (Rodrfguez-Tebar and Rohrer, 1991; Holst et al., 1997) . In one study R A exerted a specific effect on BMP-induced den drite development but not axonal elongation or survival of rat sympathetic neurons. It has there fore been suggested that retinoids function as en dogenous morphogens for neuronal cell shape and polarity (Chandrasekaran et al., 2000) . If axonal regeneration requires the reactivation of growthrelated genes that were used during embryonic differentiation but are quiescent in the adult ner vous system, it is not unreasonable to assume that RA, since it plays an im portant part in develop mental regulation of those genes, may again con trol the metabolic state of injured neurons. A pre requisite for this assumption is the functional machinery of retinoid signal transduction in the adult nervous system (Fig. 1) . 
Retinoid signal transduction with retinoids in the adult nervous system
In the vertebrate nervous system R A is synthe sized from retinaldehyde, a product of retinol oxi dation. The limiting reaction that controls the local availability of R A in vivo is the oxidation of reti naldehyde, usually catalyzed by aldehyde dehy drogenases (Napoli, 1996; Dräger and McCaffery, 1997) . These enzymes are most active in the embryo, but are also present in the adult nervous system. Neurons, glia cells and the meninges are sources of R A in the embryo and in the adult (Toresson et al., 1999; Yamamoto et al., 1999) . Western blotting with an antibody against class 1 aldehyde dehydrogenases dem onstrates that such enzymes are expressed in differentiated glia cells. OLN-93 oligodendrocytes are able to oxidize retinaldehyde and specifically synthesize all-trans RA (Mey and Ham m elm ann, 2000) . RA is also produced in the adult CNS in vivo (Dev et al., 1993) , for instance in the retina, the meso-telencephalic dopamine system and the pia m ater (McCaffery and Dräger, 1994; D räger and McCaffery, 1997; Pottek and Weiler, 2000) . Cellular retinoid binding proteins are present in many brain structures: The cellular retinoic acid binding protein CRA BP-II has been detected in neurons of the basal forebrain and stri atum, CRABP-I in the olfactory system (Z et terström et al., 1999) . Intracellular signal transduc tion of R A depends on ligand activated dimers of nuclear R A receptors. The RXRß receptor was detected in most areas of the CNS, R X R a in cor tex and hippocampus. R A R ß and RXRy are highly expressed in the dopam ine-innervated caudate/putam en, nucleus accumbens and olfactory tubercle of adult rodents (Zetterström et al., 1999) . Physiological experiments with R A R ß/R X R y knockout mice revealed impairment in spatial learning and memory of these animals (Morris water maze). They also indicate that the R A R ß-gene is necessary for long term potentiation and both genes are required for long term depression in the hippocampus (Chiang et al., 1998) . This in complete list demonstrates the presence of various components of the RA system in the adult nervous systems and suggests possible recruitm ent for sig nal transduction after traumatic injuries.
RA promotes axonal regeneration in vitro
Until recently, only embryonic neurons were known to respond to RA with neurite outgrowth. Work from my laboratory (Mey and Rombach, 1999) and experiments by Corcoran and M aden (Corcoran and Maden, 1999 ) have now shown that R A also promotes regeneration of axons by dif ferentiated nerve cells. To investigate the possi bility that R A promotes axonal regeneration of chick retinal ganglion cells synergistically with BDNF we injected all-trans RA onto the chorio allantoic membrane of stage E16 chick embryos. Following explantation of the retinas 24 hours later, axonal regeneration was m onitored in organ cultures supplemented with BDNF. RA enhanced neurite outgrowth of retinal ganglion cells 2 -to 3-fold. The dose-dependent and highly significant effect was observed only after application of R A in ovo and subsequent use of the neurotrophin. Treatment with RA alone or as a supplem ent to the culture medium produced no increase in fiber numbers (Mey and Rombach, 1999) . With neurons from dorsal root ganglia (D R G ), RA seemed to act downstream from a neurotrophin. In this case, NG F caused neurite outgrowth from D R G by acti vating the synthesis of all-trans RA: D R G cultured in the presence of NGF-blocking antibodies and R A showed neurite outgrowth equivalent to that obtained with the neurotrophin alone, whereas the action of N G F was abolished by a blocker of RAsynthesizing aldehyde dehydrogenases (Corcoran and M aden, 1999) . The stimulation of neurite out growth in NGF-and NT-3-dependent D R G neu rons by R A involves specific activation and upregulation of R A R b 2 (Corcoran et al., 2000) . Several cell culture studies show a transcriptional regula tion of retinoid receptors by cytokines, e.g. TN F-a (Sugawara et al., 1998) . Thus, the causal interac tion between retinoids and cytokines may take place in both directions.
Conclusion
The hypothesis that RA plays a role as a regula tor of cytokine signaling in the adult nervous sys tem rests on the following lines of evidence:
1. With an interest in their anti-inflammatory and anti-proliferative action retinoids have been thoroughly studied in cell culture systems. In many instances retinoids interact with those cy tokine signals that m ediate cellular interactions after nerve lesions in vivo. 2. Most com ponents of the retinoid signaling path way are present in the adult nervous system: Al dehyde dehydrogenases, cellular retinoid bind ing proteins, nuclear RA-receptors. Some of these are upregulated after traumatic injuries. 3. R A prom otes glial and neuronal differentiation including the outgrowth of axons in the devel oping spinal cord, dorsal root ganglia and sym pathetic ganglia. Some of these processes are re capitulated in regenerative processes in the injured nervous system. 4. The regeneration of differentiated retinal gan glion cells and peripheral sensory neurons is en hanced by R A in vitro.
As in the fields of cancer prevention and dermatological treatm ent, the developmental role of RA to regulate gene expression opens opportunities for the therapeutic induction of neuronal regener ation. 
